LSBio
KMO Antibody (aa155-182)

Western blot of KMO Antibody in CEM cell line lysates (35 ug/lane). KMO (arrow) was detected using the purified antibody.

KMO Antibody (aa155-182)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human, Mouse
Format:Liquid
See all Human KMO antibodies →
$401.00each
Catalog Number: LS-C165595-400

For bulk orders or custom formulations:

Request a Quote

Overview

Description
KMO antibody LS-C165595 is an unconjugated rabbit polyclonal antibody to KMO (aa155-182) from human. It is reactive with human and mouse. Validated for Flow, IHC, Peptide-ELISA and WB. Cited in 1 publication.
Application
ELISA, FC, IHC, IHC-P, WB
Reactivity
Hu, Ms
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
DJ317G22.1 | KMO | Kynurenine 3-hydroxylase | Kynurenine 3-monooxygenase
Recommended Dilution: FC
1:10 - 1:50
Recommended Dilution: IHC-P
1:10 - 1:50
Recommended Dilution: WB
1:1000
UniProt Number
O15229
SwissProt
O15229

Target

Target
Human KMO
Antigen Species
Human
Epitope
This KMO antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 155-182 amino acids from the Central region of human KMO.
Gene Name
KMO

Antibody

Host Species
Rabbit
Clonality
Polyclonal

Immunogen

Immunogen Type
Peptide

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, 0.09% Sodium Azide
Concentration
2 mg/mL
Volume
400 Microliter
Preservative
Yes
Purification Method
Protein A Affinity

Storage & Handling

Storage Conditions
Maintain refrigerated at 2°C to 8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Recommended Storage Buffer
PBS
Kynurenine 3-monooxygenase upregulates pluripotent genes through ß-catenin and promotes triple-negative breast cancer progression. Tzu-Ting Huang, Ling-Ming Tseng, Ji-Lin Chen, Pei-Yi Chu, Chia-Han Lee, Chun-Teng Huang, Wan-Lun Wang, Ka-Yi Lau, Mei-Fang Tseng, Yuan-Ya Chang, Tzu-Yi Chiang, Yune-Fang Ueng, Hsin-Chen Lee, Ming-Shen Dai, Chun-Yu Liu. EBioMedicine. 2020 Apr;54:102717. PubMed: 32268268 PMC: PMC7191260

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.